Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Preclinical, Clinical, and Translational Sciences

Rapid Fires: Novel In Silico and In Vitro Approaches in Drug Development 2

ddPCR-Based Assessment of Dendritic Cell Activation for Immunogenicity Evaluation

Monday, November 10, 2025

3:15 PM - 3:30 PM CT

Location: 225 CD

Rapid Fire Speaker(s)

Jean-Pierre Minembe, BS

Senior Research Associate Scientist II
Takeda Pharmaceutical Company Limited
Cambridge, Massachusetts

A cheaper and generic method that can be used to assess immunogenicity regardless of the drug molecule type allowing decision to be made early.